Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | VCAM1 | P19320 | 13/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19954350 | 0.91 | CA1 (0.44) | CA1CA2VCAM1ELANEEGFR | |
| SCHEMBL17270588 | 0.86 | CA1 (0.57) | CA1CA2VCAM1EGFR | |
| SCHEMBL17267257 | 0.86 | CA1 (0.41) | CA1CA2VCAM1ELANE | |
| SCHEMBL17171700 | 0.86 | CA1 (0.50) | CA1CA2VCAM1ELANE | |
| SCHEMBL17278384 | 0.84 | SMN1; SMN2 (0.46) | CA2VCAM1 | |
| SCHEMBL18202075 | 0.84 | CA1 (0.54) | CA1CA2VCAM1ELANEEGFR | |
| SCHEMBL18950758 | 0.84 | CA1 (0.38) | CA1CA2VCAM1ELANE | |
| SCHEMBL18950756 | 0.83 | CA1 (0.37) | CA1CA2VCAM1ELANE | |
| SCHEMBL17274608 | 0.81 | CA2 (0.67) | CA1CA2VCAM1EGFR | |
| SCHEMBL18682922 | 0.81 | CA1 (0.43) | CA1CA2VCAM1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3145938-B1 | METHOD FOR PRODUCING MONOPHOSPITES | EVONIK DEGUSSA GMBH (DE) | 2018-12-26 | — | — | EP | disclosed |
| EP-3145940-B1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING TWO SOLUTIONS | EVONIK DEGUSSA GMBH (DE) | 2018-12-12 | — | — | EP | disclosed |
| EP-3088405-B1 | NOVEL MONOPHOSPHIT COMPOUNDS WITH A METHYL GROUP | EVONIK DEGUSSA GMBH (DE) | 2018-11-14 | — | — | EP | disclosed |
| US-9914681-B2 | Preparation of high-quality oxo process alcohols from inconstant raw material sources | EVONIK DEGUSSA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| EP-2947064-B1 | PRODUCTION OF HIGH QUALITY OXO ALCOHOLS FROM VOLATILE RAW MATERIAL SOURCES | EVONIK DEGUSSA GMBH (DE) | 2018-01-17 | — | — | EP | disclosed |
| EP-2947064-B1 | PRODUCTION OF HIGH QUALITY OXO ALCOHOLS FROM VOLATILE RAW MATERIAL SOURCES | EVONIK DEGUSSA GMBH (DE) | 2018-01-17 | — | — | EP | disclosed |
| US-9840524-B2 | Process for reducing the chlorine content of organomonophosphites using two solutions | EVONIK DEGUSSA GMBH (DE) | 2017-12-12 | — | — | US | disclosed |
| US-9751904-B2 | Method for reducing the chlorine content of organomonophosphites using dimethylaminobutane, triethylamine or triethanolamine | EVONIK DEGUSSA GMBH (DE) | 2017-09-05 | — | — | US | disclosed |
| EP-3178828-A1 | HETEROCYCLIC SELENA PHOSPHITES AND METHOD FOR THE PRODUCTION THEREOF | Evonik Degussa GmbH (DE) | 2017-06-14 | — | — | EP | disclosed |
| EP-3178828-A1 | HETEROCYCLIC SELENA PHOSPHITES AND METHOD FOR THE PRODUCTION THEREOF | Evonik Degussa GmbH (DE) | 2017-06-14 | — | — | EP | disclosed |
| US-20150336987-A1 | NOVEL MONOPHOSPHITE LIGANDS HAVING A CARBONATE GROUP | EVONIK INDUSTRIES AG (DE) | 2015-11-26 | — | — | US | disclosed |
| WO-2015176929-A1 | METHOD FOR REDUCING THE CHLORINE CONTENT OF ORGANOMONOPHOSPHITES USING DIMETHYLAMINOBUTANE, TRIETHYLAMINE OR TRIETHANOLAMINE | EVONIK DEGUSSA GMBH (DE) | 2015-11-26 | — | — | WO | disclosed |
| EP-2947089-A1 | NOVEL MONOPHOSPHITE LIGANDS WITH A CARBONATE GROUP | Evonik Degussa GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947064-A1 | PRODUCTION OF HIGH QUALITY OXO ALCOHOLS FROM VOLATILE RAW MATERIAL SOURCES | Evonik Degussa GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947091-A1 | MIXTURES OF MONOPHOSPHITE LIGAND AND THEIR USE IN THE CATALYSIS OF A HYDROFORMYLATION REACTION | Evonik Industries AG (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947089-A1 | NOVEL MONOPHOSPHITE LIGANDS WITH A CARBONATE GROUP | Evonik Degussa GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947090-A1 | NOVEL MONOPHOSPHITE LIGANDS WITH A TERTIARY BUTYLOXYCARBONYL GROUP | Evonik Industries AG (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947091-A1 | MIXTURES OF MONOPHOSPHITE LIGAND AND THEIR USE IN THE CATALYSIS OF A HYDROFORMYLATION REACTION | Evonik Industries AG (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947064-A1 | PRODUCTION OF HIGH QUALITY OXO ALCOHOLS FROM VOLATILE RAW MATERIAL SOURCES | Evonik Degussa GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2947090-A1 | NOVEL MONOPHOSPHITE LIGANDS WITH A TERTIARY BUTYLOXYCARBONYL GROUP | Evonik Industries AG (DE) | 2015-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336987-A1 | NOVEL MONOPHOSPHITE LIGANDS HAVING A CARBONATE GROUP | M6PR, NUDT1, PHOSPHO1 | CA1 172/4885CA2 140/4885VCAM1 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.